Focused Shockwave Therapy Device

The FDA Approved Focused Shockwave is the next generation of ESWT Extracorporeal Shock Wave Treatment with patented focused “Cylindrical Source“ Technology available from CuraMedix. This unique device leads the industry in innovation and performance for the treatment of pain associated with chronic proximal plantar fasciitis.

Schedule a Demo
Request Pricing

Focused Shockwave Therapy: How It Works

This Focused Shockwave device, the DuoLith SD1 TTOP Ultra, uses an electromagnetically generated shock wave produced within a hand-held applicator (F-SW Handpiece). The shockwave is generated by discharging a high voltage capacitor located in the control unit into a cylindrically shaped coil system in the handpiece which is surrounded by a cylindrical metallic membrane. The transient magnetic field produced by the coil induces eddy currents in the metal membrane, causing it to repel from the coil, producing a pressure wave. The membrane is immersed in water and the pressure wave produced by the membrane propagates through the water to a concentric parabolic reflector, where it is reflected to a focal point outside of the handpiece in front of the reflector.
Focused Shockwave Therapy Device

The Benefits:

With its progressive technological advancements, Extracorporeal Pulse Activation Technology (EPAT/ESWT) delivers an evidence-based*, non-surgical solution for patients suffering from chronic heel pain.

It addresses the increasing demand for patient convenience, less down-time and risk, as well as better clinical and economic outcomes, and improved practice efficiencies and cash-flow.

Health care professionals are using ESWT to successfully treat acute or chronic musculoskeletal pain and/or

  • Foot and ankle
  • Lower extremity
  • Upper extremity
  • Back and chest
  • Shoulder
  • Neck
  • Myofascial trigger points

Is focused ESWT effective in relieving chronic heel pain diagnosed as plantar fasciitis?

Check out the study published in The Journal of Bone Joint Surgery “Clinically relevant effectiveness of focused extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis: a randomized, controlled multicenter study.”

Backed By Evidence and Clinical Research

The best way to advance patient care for your practice is looking to the evidence that’s available for new technologies and protocols. CuraMedix solutions like AWT are backed by clinical studies and are evidence-based; whereas similar competing technologies cannot make this claim.